AI is no longer a future conversation in pharma. Many organizations have experimented, but very few have successfully scaled AI into real, enterprise-wide impact. This event goes beyond the basics to explore what it actually takes to move from early pilots to sustained capability. You will hear from leaders who are actively building and scaling AI across commercial and enterprise functions, sharing honest insights on what worked, what failed, and how they adapted along the way.
The discussion will unpack the organizational, cultural, and governance shifts required to make AI work in a regulated environment, while also looking ahead to how roles and capabilities will evolve over the next few years.
Attendees will leave with practical perspectives, clearer frameworks, and the confidence to move from experimenting with AI to leading its impact within their organizations.